DRNA - Dicerna Pharmaceuticals EPS beats by $0.28 beats on revenue November, 09 2021 07:33 AM Dicerna Pharmaceuticals Inc. Dicerna Pharmaceuticals (NASDAQ:DRNA): Q3 GAAP EPS of -$0.22 beats by $0.28. Revenue of $62.95M (+28.8% Y/Y) beats by $19.17M. Press Release For further details see: Dicerna Pharmaceuticals EPS beats by $0.28, beats on revenue